Literature DB >> 19136576

Neutrophil elastase cleaves VEGF to generate a VEGF fragment with altered activity.

Elma Kurtagic1, Mark P Jedrychowski, Matthew A Nugent.   

Abstract

Excessive neutrophil elastase (NE) activity and altered vascular endothelial growth factor (VEGF) signaling have independently been implicated in the development and progression of pulmonary emphysema. In the present study, we investigated the potential link between NE and VEGF. We noted that VEGF(165) is a substrate for NE. Digestion of purified VEGF(165) with NE generated a partially degraded disulfide-linked fragment of VEGF. Mass spectrometric analysis revealed that NE likely cleaves VEGF(165) at both the NH(2) and COOH termini to produce VEGF fragment chains approximately 5 kDa reduced in size. NE treatment of VEGF-laden endothelial cell cultures and smooth muscle cells endogenously expressing VEGF generated VEGF fragments similar to those observed with purified VEGF(165). NE-generated VEGF fragment showed significantly reduced binding to VEGF receptor 2 and heparin yet retained the ability to bind to VEGF receptor 1. Interestingly, VEGF fragment showed altered signaling in pulmonary artery endothelial cells compared with intact VEGF(165). Specifically, treatment with VEGF fragment did not activate extracellular-regulated kinases 1 and 2 (ERK1/2), yet resulted in enhanced activation of protein kinase B (Akt). Treatment of monocyte/macrophage RAW 264.7 cells with VEGF fragment, on the other hand, led to both Akt and ERK1/2 activation, increased VEGFR1 expression, and stimulated chemotaxis. These findings suggest that the tissue response to NE-mediated injury might involve the generation of diffusible VEGF fragments that stimulate inflammatory cell recruitment and activation via VEGF receptor 1.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19136576      PMCID: PMC2660218          DOI: 10.1152/ajplung.90505.2008

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN: 1040-0605            Impact factor:   5.464


  82 in total

1.  Vascular endothelial growth factor: crystal structure and functional mapping of the kinase domain receptor binding site.

Authors:  Y A Muller; B Li; H W Christinger; J A Wells; B C Cunningham; A M de Vos
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-08       Impact factor: 11.205

2.  Regulation of flt-1 expression during mouse embryogenesis suggests a role in the establishment of vascular endothelium.

Authors:  G H Fong; J Klingensmith; C R Wood; J Rossant; M L Breitman
Journal:  Dev Dyn       Date:  1996-09       Impact factor: 3.780

3.  The vascular endothelial growth factor receptor Flt-1 mediates biological activities. Implications for a functional role of placenta growth factor in monocyte activation and chemotaxis.

Authors:  M Clauss; H Weich; G Breier; U Knies; W Röckl; J Waltenberger; W Risau
Journal:  J Biol Chem       Date:  1996-07-26       Impact factor: 5.157

4.  Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium.

Authors:  G H Fong; J Rossant; M Gertsenstein; M L Breitman
Journal:  Nature       Date:  1995-07-06       Impact factor: 49.962

5.  The vascular endothelial growth factor (VEGF) isoforms: differential deposition into the subepithelial extracellular matrix and bioactivity of extracellular matrix-bound VEGF.

Authors:  J E Park; G A Keller; N Ferrara
Journal:  Mol Biol Cell       Date:  1993-12       Impact factor: 4.138

6.  Myeloid progenitor cell regulatory effects of vascular endothelial cell growth factor.

Authors:  H E Broxmeyer; S Cooper; Z H Li; L Lu; H Y Song; B S Kwon; R E Warren; D B Donner
Journal:  Int J Hematol       Date:  1995-12       Impact factor: 2.490

7.  Placenta growth factor. Potentiation of vascular endothelial growth factor bioactivity, in vitro and in vivo, and high affinity binding to Flt-1 but not to Flk-1/KDR.

Authors:  J E Park; H H Chen; J Winer; K A Houck; N Ferrara
Journal:  J Biol Chem       Date:  1994-10-14       Impact factor: 5.157

8.  Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1.

Authors:  B Barleon; S Sozzani; D Zhou; H A Weich; A Mantovani; D Marmé
Journal:  Blood       Date:  1996-04-15       Impact factor: 22.113

9.  Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele.

Authors:  P Carmeliet; V Ferreira; G Breier; S Pollefeyt; L Kieckens; M Gertsenstein; M Fahrig; A Vandenhoeck; K Harpal; C Eberhardt; C Declercq; J Pawling; L Moons; D Collen; W Risau; A Nagy
Journal:  Nature       Date:  1996-04-04       Impact factor: 49.962

10.  Elastase release of basic fibroblast growth factor in pulmonary fibroblast cultures results in down-regulation of elastin gene transcription. A role for basic fibroblast growth factor in regulating lung repair.

Authors:  C B Rich; M A Nugent; P Stone; J A Foster
Journal:  J Biol Chem       Date:  1996-09-20       Impact factor: 5.157

View more
  20 in total

1.  RIG-like helicase innate immunity inhibits vascular endothelial growth factor tissue responses via a type I IFN-dependent mechanism.

Authors:  Bing Ma; Charles S Dela Cruz; Dominik Hartl; Min-Jong Kang; Shervin Takyar; Robert J Homer; Chun Geun Lee; Jack A Elias
Journal:  Am J Respir Crit Care Med       Date:  2011-01-28       Impact factor: 21.405

2.  Identification of mannose receptor as receptor for hepatocyte growth factor β-chain: novel ligand-receptor pathway for enhancing macrophage phagocytosis.

Authors:  Hiroyuki Ohnishi; Kiyomasa Oka; Shinya Mizuno; Toshikazu Nakamura
Journal:  J Biol Chem       Date:  2012-02-21       Impact factor: 5.157

Review 3.  Studies of vascular endothelial growth factor in asthma and chronic obstructive pulmonary disease.

Authors:  Chun Geun Lee; Bing Ma; Seyedtaghi Takyar; Farida Ahangari; Charles Delacruz; Chuan Hua He; Jack A Elias
Journal:  Proc Am Thorac Soc       Date:  2011-11

Review 4.  Extracellular regulation of VEGF: isoforms, proteolysis, and vascular patterning.

Authors:  Prakash Vempati; Aleksander S Popel; Feilim Mac Gabhann
Journal:  Cytokine Growth Factor Rev       Date:  2013-11-27       Impact factor: 7.638

5.  Enhanced Survival and Accelerated Perfusion of Skin Flap to Recipient Site Following Administration of Human α1-Antitrypsin in Murine Models.

Authors:  Ronen Schuster; Or Bar-Nathan; Alon Tiosano; Eli C Lewis; Eldad Silberstein
Journal:  Adv Wound Care (New Rochelle)       Date:  2019-07-02       Impact factor: 4.730

Review 6.  Expanding the clinical indications for α(1)-antitrypsin therapy.

Authors:  Eli C Lewis
Journal:  Mol Med       Date:  2012-09-07       Impact factor: 6.354

7.  Cigarette-smoke-induced oxidative/nitrosative stress impairs VEGF- and fluid-shear-stress-mediated signaling in endothelial cells.

Authors:  Indika Edirisinghe; Gnanapragasam Arunachalam; Chelsea Wong; Hongwei Yao; Arshad Rahman; Richard P Phipps; Zheng-Gen Jin; Irfan Rahman
Journal:  Antioxid Redox Signal       Date:  2010-06-15       Impact factor: 8.401

8.  Mesenchymal stem cell-based HSP70 promoter-driven VEGFA induction by resveratrol alleviates elastase-induced emphysema in a mouse model.

Authors:  Young-Bin Chen; Ying-Wei Lan; Lih-Geeng Chen; Tsung-Teng Huang; Kong-Bung Choo; Winston T K Cheng; Hsuan-Shu Lee; Kowit-Yu Chong
Journal:  Cell Stress Chaperones       Date:  2015-08-05       Impact factor: 3.667

9.  Quantifying the proteolytic release of extracellular matrix-sequestered VEGF with a computational model.

Authors:  Prakash Vempati; Feilim Mac Gabhann; Aleksander S Popel
Journal:  PLoS One       Date:  2010-07-29       Impact factor: 3.240

10.  The Prominin-1-Derived Peptide Improves Cardiac Function Following Ischemia.

Authors:  Avner Adini; Irit Adini; Etty Grad; Yuval Tal; Haim D Danenberg; Peter M Kang; Benjamin D Matthews; Robert J D'Amato
Journal:  Int J Mol Sci       Date:  2021-05-13       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.